Clinical trial
Celgosivir Proof of Concept Trial for Treatment of Acute Dengue Fever
NCT01619969 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Celgosivir Proof of Concept Trial for Treatment of Acute Dengue Fever
- Lead sponsor
- Singapore General Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- July 31, 2013
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dengue fever